Article Details

Bioengineered ankyrin compounds show high in vitro activity against SARS-CoV-2 mutants

Retrieved on: 2021-02-08 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

Bioengineered ankyrin compounds show high in vitro activity against SARS-CoV-2 mutants. View article details on hiswai:

Excerpt

To retain the potency of neutralizing monoclonal antibodies, they were proposed to be used in cocktails, targeting distinct neutralizing epitopes and ...

Article found on: www.news-medical.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up